🇺🇸 Carvedilol 25mg in United States

63 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Death — 11 reports (17.46%)
  2. Dyspnoea — 8 reports (12.7%)
  3. Fatigue — 8 reports (12.7%)
  4. Dizziness — 7 reports (11.11%)
  5. Diarrhoea — 6 reports (9.52%)
  6. Hypotension — 6 reports (9.52%)
  7. Bradycardia — 5 reports (7.94%)
  8. Acute Kidney Injury — 4 reports (6.35%)
  9. Asthenia — 4 reports (6.35%)
  10. Syncope — 4 reports (6.35%)

Source database →

Carvedilol 25mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Carvedilol 25mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Carvedilol 25mg in United States?

Ahn-Gook Pharmaceuticals Co.,Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.